Categories: News

Tiger BioSciences Headlines IPAWS Conference, Showcases Extensive Clinical Data in Wound Care

CONSHOHOCKEN, Pa., Nov. 14, 2025 /PRNewswire/ — Tiger BioSciences proudly served as the headline sponsor of the International Post-Acute Wound Care Society Summit (IPAWS) Conference, held November 13–14. At the event, Tiger BioSciences reinforced its leadership in wound care innovation by presenting significant peer-reviewed clinical information and highlighting its data-driven approach to advancing patient outcomes. 

“Our participation at IPAWS reflects Tiger BioSciences’ dedication to advancing wound care through science, innovation, and collaboration with leading experts,” said Garrett Grinsfelder, President of Tiger Wound Care. “Presenting our real-world evidence highlights our commitment to data-driven insights, the meaningful clinical impact of our products, and our goal of equipping clinicians with solutions that improve patient outcomes.” 

Just this year alone, Tiger BioSciences supported five peer-reviewed retrospective manuscripts across various wound etiologies, including chronic, surgical, and traumatic wounds. These publications provide valuable insight into the real-world applications and outcomes of Tiger BioSciences’ groundbreaking and innovative cellular, acellular, and matrix-like products (CAMPs). 

Furthermore, the company is conducting two randomized controlled trials (RCTs) evaluating ACApatch and caregraFT, in combination with Standard of Care, for patients diagnosed with venous leg, diabetic foot, and pressure ulcers.

About Tiger BioSciences 

Tiger BioSciences is a vertically integrated cell and tissue technology company entrenched in every aspect of recovery, processing, technology development, R&D, and distribution of groundbreaking cellular, acellular, matrix-like products (CAMPs). Through its companies, Tiger BioSciences functions as a tissue recovery agency, processing and technology innovator, and trusted commercial partners to clinicians. 

At its core, Tiger BioSciences is committed to patients, providers, and the donor families whose selfless contributions make these innovations possible.

View original content to download multimedia:https://www.prnewswire.com/news-releases/tiger-biosciences-headlines-ipaws-conference-showcases-extensive-clinical-data-in-wound-care-302615748.html

SOURCE Tiger BioSciences

Staff

Recent Posts

Abbott Laboratories Announces Measurable Results From LATAM Diagnostic Market Development and Training Initiative Led by Claudia Marcela Riaño Caro

Regional program delivers double-digit sales growth, improved service performance, and expanded diagnostic access across Latin…

3 hours ago

GEARWRENCH Continues to Redefine Automotive Diagnostics with Powerful New Tools

Four new products available now to put full diagnostics in the palm of technician's handsSPARKS,…

4 hours ago

Tampa General’s Innovation Week Returns with New Programming to Showcase Breakthroughs in Patient Care and Technology

Global leaders, entrepreneurs and innovators will converge across the Tampa Medical & Research District and…

4 hours ago

New England Biolabs ® Proudly Partners with Automation Providers to Support NGS Library Prep Automation Globally

IPSWICH, Mass., Feb. 6, 2026 /PRNewswire/ -- New England Biolabs (NEB ®) will present several…

4 hours ago

Healthcare Triangle, Inc. Announces 1-for-60 Reverse Stock Split as Part of Nasdaq Compliance Plan

PLEASANTON, Calif., Feb. 6, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"),…

9 hours ago

Rokt Joins American Heart Association’s “Go Red. Shop with Heart” Initiative, Marks Kickoff at NYSE Bell Ringing

NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Rokt, the leading ecommerce technology company using machine learning…

9 hours ago